Connect with us

Business

Total coronavirus cases in Ottawa surpass 14,000 – CTV Edmonton

Published

 on


OTTAWA —
Ottawa Public Health says 59 more people in Ottawa have tested positive for COVID-19 and one more person has died.

According to OPH’s COVID-19 dashboard, there have been 14,007 total laboratory-confirmed cases of COVID-19 in Ottawa since the pandemic began and 433 residents have died.

There was no update from Ontario health officials today due to the Family Day holiday.

Ottawa Public Health is also reporting an increase in the number of known active cases in the city for the fifth day in a row after active cases hit a 2021 low of 402 on Feb. 10.

The number of people in hospital has also increased, but remains below 20.

This is the final day of a stay-at-home order for Ottawa. Starting Tuesday, Ottawa will return to the “Orange-Restrict” level under Ontario’s colour-coded COVID-19 framework. 

OTTAWA’S COVID-19 KEY STATISTICS

Ottawa Public Health will be moved to the “Orange-Restrict” status under Ontario’s COVID-19 framework at 12:01 a.m. Feb. 16.

Ottawa Public Health data:

  • COVID-19 cases per 100,000 (previous seven days): 28.5 (up from 26.0 cases on Sunday and 27.6 cases on Saturday)
  • Positivity rate in Ottawa: 1.6 per cent (Feb. 8-14)
  • Reproduction number: 1.00 (seven day average)

Reproduction values greater than 1 indicate the virus is spreading and each case infects more than one contact. If it is less than 1, it means spread is slowing.

The Orange-Restrict category of Ontario’s COVID-19 framework includes a weekly rate of cases per 100,000 between 25 to 39.9, a percent positivity of 1.3 to 2.4 per cent, and a reproduction number of approximately 1 to 1.1.  

VACCINES IN OTTAWA

As of Feb. 12

  • Vaccine doses administered in Ottawa (first and second shots): 38,030*
  • Pfizer-BioNTech COVID-19 vaccine doses received: 35,100
  • Moderna COVID-19 vaccine doses received: 4,000

*OPH says staff were able to extract additional doses out of several vials, which were given to residents. In a statement on its dashboard, OPH said, “Vaccine inventory is based on an expected 5 dose per vial supply. Occasionally, an additional dose (6th dose) is successfully extracted and administered to clients.” 

ACTIVE CASES OF COVID-19 IN OTTAWA

The number of people with known active cases of COVID-19 in Ottawa rose to 438 from 426 on Sunday.

This is the fifth day in a row that active cases in the city have been increasing, after hitting a 2021 low of 402 on Feb. 10.

OPH reported 46 newly resolved cases of COVID-19 in Ottawa on Monday, bringing the city’s total to 13,136.

The number of active cases is the number of total laboratory-confirmed cases of COVID-19 minus the numbers of resolved cases and deaths. A case is considered resolved 14 days after known symptom onset or positive test result.

HOSPITALIZATIONS IN OTTAWA

There are 17 people in Ottawa hospitals with COVID-19 complications, up from 13 on Sunday. Three people remain in intensive care.

Of the people in hospital, two are in their 40s, two are in their 50s, five are in their 60s, five are in their 70s (two are in the ICU), and three are in their 80s (one is in the ICU), 

COVID-19 CASES IN OTTAWA BY AGE CATEGORY

  • 0-9 years old: Two new cases (1,033 total cases)
  • 10-19 years-old: Nine new case (1,726 total cases)
  • 20-29 years-old: 17 new cases (2,989 total cases)
  • 30-39 years-old: Four new cases (1,965 total cases)
  • 40-49 years-old: 11 new cases (1,825 total cases)
  • 50-59 years-old: Eight new cases (1,688 total cases)
  • 60-69-years-old: Three new cases (1,024 total cases)
  • 70-79 years-old: Two new cases (627 total cases)
  • 80-89 years-old: Two new cases (686 total cases)
  • 90+ years old: Zero new cases (440 total cases)
  • Unknown: One new case (4 cases total)

INSTITUTIONAL OUTBREAKS

Ottawa Public Health is reporting COVID-19 outbreaks at 24 institutions in Ottawa, including long-term care homes, retirement homes, daycares, hospitals and schools.

No new outbreaks were declared on Monday. An outbreak at the Oakpark Retirement Community has ended

There are seven active community outbreaks, two are linked to retail workplaces, two are linked to health workplaces, one is linked to a corporate/office setting, one is linked to a distribution centre, and one is linked to a warehouse.

The schools and childcare spaces currently experiencing outbreaks are:

  1. Bishop Hamilton Montessori School
  2. Centre educatif La Clementine (École Marie-Curie)
  3. Charles H. Hulse Public School
  4. CityView – Home Child Care – 32814
  5. CityView – Home Child Care – 32912 
  6. Mothercraft Ottawa home child care – 32715
  7. Playtime Daycare Centre – Licensed Childcare

The long-term care homes, retirement homes, hospitals, and other spaces currently experiencing outbreaks are:

  1. Carlingwood Retirement 
  2. Extendicare Starwood 
  3. Garry J. Armstrong long-term care home
  4. Group Home – 32432
  5. Group Home – 32782
  6. Maison Acceuil Sagesse
  7. Manoir Marochel
  8. Montfort Long-term Care Centre
  9. Residence St. Louis
  10. Shelter – 28778
  11. Shelter – 29677
  12. Shelter – 29770
  13. Shelter – 29860
  14. Shelter – 32620
  15. Supported Independent Living – 32891
  16. The Edinburgh Retirement Residence
  17. Villa Marconi

A single laboratory-confirmed case of COVID-19 in a resident or staff member of a long-term care home, retirement home or shelter triggers an outbreak response, according to Ottawa Public Health. In childcare settings, a single confirmed, symptomatic case in a staff member, home daycare provider, or child triggers an outbreak.

Under provincial guidelines, a COVID-19 outbreak in a school is defined as two or more lab-confirmed COVID-19 cases in students and/or staff in a school with an epidemiological link, within a 14-day period, where at least one case could have reasonably acquired their infection in the school (including transportation and before or after school care).  

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Trudeau 'very optimistic' vaccine rollout can be accelerated and move closer to U.S. goals – National Post

Published

 on


Trudeau held to his September target, but said with vaccine deliveries being moved up and new candidates being approved, the timeline could be moved up

Article content

OTTAWA – Prime Minister Justin Trudeau said Wednesday morning he was hopeful Canada’s vaccine timelines could be moved up, but offered no assurance the vaccine rollout here won’t be completed months after the United States.

But late on Wednesday afternoon, a national panel of vaccine experts recommended extending the interval between the two doses of a COVID-19 shot when faced with a limited supply.

Canada’s National Advisory Committee on Immunization’s updated guidance is for the administration of all COVID-19 vaccines currently approved for use in Canada. It says extending the dose interval to four months will create opportunities to protect the entire adult population against the virus within a shorter timeframe.

U.S. President Joe Biden said Tuesday evening America would have enough vaccines delivered to cover the entire population by late May. The rollout of those vaccines into arms will follow, but America is still likely to be able to vaccinate its entire population months ahead of Canada.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

Trudeau’s long-held timeline is to have all Canadians vaccinated by the end of September. He held to that target at his Wednesday morning press conference, but said with vaccine deliveries being moved up and new candidates being approved, it is possible the timeline could be moved up.

“We’re very optimistic that we’re going to be able to accelerate some of these timelines,” he said. “We’re going to continue to do everything we can to allow our population to get through this challenge as quickly as possible,” he said.

  1. Public health measures like masking are being recommended regardless of if someone has been vaccinated.

    What happens after my COVID shots? Masking, social-distancing, still recommended, but some experts want different approach

  2. Federal Procurement Minister Anita Anand.

    Liberals confident U.S. AstraZeneca vaccines will be delivered despite Biden’s ‘America first’ strategy

Trudeau said COVID has had a much more devastating impact on the U.S. and that will have a significant impact on the recovery.

“Obviously, the pandemic has had a very different course in the United States with far greater death tolls and case counts and that has had its own impact on the American economy,” he said.

Conservative MP Michelle Rempel Garner, the party’s health critic, said the government should be providing a clearer, more detailed explanation of its vaccine plan, to help businesses have confidence about what comes next.

“We don’t have any of that data. We don’t actually know what the realistic time horizon is for delivery of vaccines,” she said.

With Canada set to be months behind the U.S., United Kingdom and potentially other countries in the rollout, Rempel Garner said the government should be offering information about what else it will do to ease the pandemic in the meantime.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“I think we’ll have a problem on compliance and certainty for business reopening, so this is why we’re saying look, be honest with Canadians, and then let’s work together to come up with a plan B,” she said. “COVID fatigue is a real thing. There’s a lot of frustration.”

Trudeau announced that both the government’s rent subsidy for small business and the wage subsidy will be extended into June as the pandemic continues. The extension of the rent subsidy is forecasted to cost an additional $2.1 billion and the wage subsidy will cost the government an additional $13.9 billion.

Finance Minister Chyrstia Freeland said the government would continue to support businesses with the goal of keeping the economy moving so it can resurge quickly when restrictions are lifted.

“Our government will continue to do whatever it takes for as long as it takes to help Canadians through this bleak time, to prevent economic scarring and invest in a way that allows us all to come roaring back,” she said.

Biden moved up his timeline to May, from what had been the end of July, after announcing the U.S. government had approved a third vaccine candidate from Johnson and Johnson. Canada is expected to approve that vaccine soon.

Canada received 500,000 doses of the AstraZeneca vaccine, the first shipment in a total of two million doses expected before mid-May, on top of a further 20 million doses expected between April and September.

Despite all the recent vaccine announcements, Trudeau said it was too early to formally move up the deadline, because there could still be issues with manufacturing or deliveries.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“These are new processes for new vaccines that are being manufactured in the millions and even billions in order to cover everyone on Earth,” he said. “We’ll be facing continued challenges, which is one of the reasons why we made such a deliberate effort to sign more deals with more different companies than many of our fellow countries.”

While the Biden administration has said it won’t ship vaccines from the U.S. to other countries until all Americans are vaccinated, Trudeau said Biden knows the challenge is global.

“It was very clear that they understand, like us, we know that you don’t get through this pandemic, anywhere, not fully, until you get through it everywhere.”

— With files from The Canadian Press

• Email: rtumilty@postmedia.com | Twitter:

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Nova Scotia to accept shipment of AstraZeneca's COVID-19 vaccine – HalifaxToday.ca

Published

 on


Nova Scotia has decided to receive its first shipment of the Oxford-AstraZeneca vaccine.

Next week, the province will get 13,000 doses of the third COVID-19 vaccine approved for use by Health Canada.

They don’t have a long shelf life and must be used by April 2.

Because of that, even though it is a two dose vaccine, the province announced today it plans to administer all of the supply as first doses. They will be going into the arms of Nova Scotians between the ages of 50 and 64 at 26 locations throughout the province on a first-come, first-served basis.

Earlier this week, the National Advisory Committee on Immunization recommended the Oxford-AstraZeneca only be used for people between the ages of 18 and 64.

“AstraZeneca is different than the two vaccines we’re using now,” explained the province’s chief medical officer of health at Tuesday’s briefing. “The Pfizer-BioNtech and the Moderna are mRNA vaccines, which have been shown to be 94 to 95 per cent effective in preventing symptomatic COVID-19 illness.”

“The AstraZeneca is slightly different. It’s called a viral-vector vaccine and it’s been shown to be about 62 per cent effective against preventing symptomatic illness.”

Because of that, Dr. Robert Strang said it won’t be used for any group considered to be a high risk for severe disease and/or exposure.

Unlike the mRNA vaccines, the Oxford-AstraZeneca vaccine does contain a virus, however the province says it isn’t the one that causes COVID-19. It’s a “different, harmless virus that triggers an immune response.”

The vaccine also doesn’t need the cold or ultra-low cold storage that the other two require. It can be stored between 2 and 8 degrees Celsius, which is similar to the standard flu vaccine.

Doctors Nova Scotia and the Pharmacy Association of Nova Scotia will be handling the launch.

“This vaccine provides another tool in our fight against COVID-19 and builds on the roll-out that is already underway in our province as we work to vaccinate all Nova Scotians,” said Premier Iain Rankin in a news release. “We have to move fast as we are mindful of the fact that we have a short window to use it given that they will expire in a month.”

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Redacted Novavax COVID-19 vaccine contract for Canada released in U.S. regulatory filings – National Post

Published

 on


All of Canada’s seven vaccine contracts have been kept confidential since they were signed last year and the government has fought against their disclosure

Article content

OTTAWA – Canada’s agreement with COVID-19 vaccine manufacturer Novavax has been released in regulatory filings, showing the drug maker has set delivery schedules, but also has broad leeway to miss them for a variety of reasons.

Novavax was the fifth vaccine maker to submit their COVID-19 vaccine to Health Canada for regulatory approval and could be given the green light as early as April. The company has a deal to provide at least 52 million doses and as many as 76 million doses of its two-dose vaccine to Canada.

All of Canada’s seven vaccine contracts have been kept confidential since they were signed last year and the government has fought moves in parliament to force the disclosure of the contracts. The released contract is still heavily redacted, with all the details on price, deliveries and penalties for missed timelines for Novavax blacked out.

The contract, filed with the U.S Securities and Exchange Commission on Monday, does specifically acknowledge there are many problems that could prevent the company from making its deliveries on time.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

“Customer acknowledges that the delivery schedule may change due to several variables. Including but not limited to speed of clinical trial enrolment and accrual of events, manufacturing delays and/or timing of regulatory approval,” reads the contract. It also specifies the delivery schedule is an “estimate only.”

Under the deal, Novavax is set to deliver vaccines monthly to Canada and like other vaccine manufacturers has quarterly targets, though the specifics of those targets are redacted from the deal. The government agreed to pay up front for the vaccines, in part because the company agreed to manufacture doses ahead of regulatory approval so they can be moved out quickly after the vaccine is approved.

  1. Procurement Minister Anita Anand  announces a delay to COVID vaccine delivery via videoconference, Friday, January 15, 2021 in Ottawa.

    MPs pass motion requiring Liberal government to let them see COVID vaccine contracts

  2. None

    Federal government signs deal to make Novavax COVID vaccine at Montreal facility still being built

The company’s CEO has said they could produce as many as 150 million doses per month starting in May. They have also signed deals with the United Kingdom, United States and several other countries, but Canada is one of the biggest orders.

If Novavax misses targets it has the opportunity to catch up and if they continue to fail Canada has the ability to cancel the agreement. Canada paid an upfront payment, but it is unclear how much Canada would be out if it cancelled the contract.

The deal does specify the company has to make “commercially reasonable efforts” to deliver on the contract, a phrase, which also exists in the company’s contracts with U.K. and Australia, though its specific definition is redacted.

Advertisement

Story continues below

This advertisement has not loaded yet, but your article continues below.

Article content

On deliveries, the U.K. and Australia’s contract includes similar language, but the U.K deal includes lots of specifics on the company’s commitment to attempt to manufacture the vaccine in British facilities.

Medical lab scientists work on samples collected in the Novavax phase 3 COVID-19 clinical vaccine trial at Harborview Medical Center on February 12, 2021 in Seattle, Washington.
Medical lab scientists work on samples collected in the Novavax phase 3 COVID-19 clinical vaccine trial at Harborview Medical Center on February 12, 2021 in Seattle, Washington. Photo by Karen Ducey/Getty Images

The company has also signed a deal to produce its vaccine on Canadian soil, at the National Research Council’s under construction facility in Montreal, but that was not part of the original agreement.

The Montreal facility is expected to take until late December to actually produce doses, and Canada’s first shipments are expected to come from other countries.

The regulatory documents include the detail that the company is committed to go further and will expand its presence in Canada

“The MOU also includes a broader intention for the Government of Canada and us to work together to increase our Canadian presence,” reads the filling. “We will explore a range of partnership opportunities for us to expand vaccine production in Canada, including partnerships with Canadian contract manufacture.”

• Email: rtumilty@postmedia.com | Twitter:

Comments

Postmedia is committed to maintaining a lively but civil forum for discussion and encourage all readers to share their views on our articles. Comments may take up to an hour for moderation before appearing on the site. We ask you to keep your comments relevant and respectful. We have enabled email notifications—you will now receive an email if you receive a reply to your comment, there is an update to a comment thread you follow or if a user you follow comments. Visit our Community Guidelines for more information and details on how to adjust your email settings.

Let’s block ads! (Why?)



Source link

Continue Reading

Trending